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Abstract
Background/Aims: Oxidative stress and mitochondria dysfunction could be involved in the 
onset of non-alcoholic fatty liver disease (NAFLD) and in its progression to non-alcoholic 
steatohepatitis (NASH). Estrogens/phytoestrogens could counteract liver fat deposition with 
beneficial effects against NAFLD by unclear mechanisms. We aimed to analyze the protective 
effects elicited by genistein/estradiol in hepatocytes cultured in NAFLD-like medium on cell 
viability, triglycerides accumulation, mitochondrial function and oxidative stress and the role 
of NLRP3 inflammasome, toll like receptors 4 (TLR4), Akt and 5’ AMP-activated protein kinase 
(AMPK)α1/2. Methods: Human primary hepatocytes/hepatoma cell line (Huh7.5 cells) were 
incubated with a 2 mM mixture of oleate/palmitate in presence/absence of genistein/17β-
estradiol. In some experiments, Huh7.5 cells were exposed to various inhibitors of the above 
pathways and estrogenic receptors (ERs) and G protein-coupled estrogen receptor (GPER) 
blockers, before genistein/17β-estradiol. Cell viability, mitochondrial membrane potential, 
reactive oxygen species and triglycerides content were examined by 3-[4,5-dimethylthiazol-
2-yl]-2,5-diphenyl tetrazolium bromide (MTT), 5,51,6,61-tetrachloro-1,11,3,31 tetraethylbenz-
imidazolyl carbocyanine iodide (JC-1), 2,7-dichlorodihydrofluorescein diacetate (H2DCFDA) 
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and the Triglyceride Colorimetric Assay. The expression/activation of kinases was analyzed 
by means of Western blot. Results: Genistein/17β-estradiol protected hepatocytes against 
NAFLD-like medium, by preventing the loss of cell viability and mitochondrial function, tri-
glycerides accumulation and peroxidation. The blocking of kinases, ERs and GPER was able 
to reduce the above effects, which were potentiated by NLRP3 inflammasome. Conclusion: 
Our findings suggest novel mechanisms underlying the protective effects elicited by phy-
toestrogens/estrogens against NAFLD/NASH and open novel therapeutic perspectives in the 
management of NAFLD in postmenopausal women.
Introduction
Mechanisms related to oxidative stress could be involved in lipid accumulation at the 
onset of non-alcoholic fatty liver disease (NAFLD) and along its transition towards non-
alcoholic steatohepatitis (NASH) [1]. Mitochondria dysfunction has been widely reported to 
play a significant role in the onset of NAFLD and in its progression, as well [2]. Conceivably, 
intracellular free fatty acid (FFAs) accumulation could interfere with mitochondria 
respiratory chain, causing proton leakage, reducing mitochondrial membrane potential and 
increasing free oxygen radical generation (ROS). In turn, ROS release would potentiate all the 
above processes [3, 4]. Factors like phosphoinositide 3-kinases (PI3K)/Akt, sterol regulatory 
element binding protein 1c (SREBP-1C), peroxisome proliferator activating ligand receptors 
(PPARs) and AMP-activated protein kinase (AMPK) are deeply involved in the control of 
lipogenesis/beta oxidation [5-7]. Hence, in experimental NAFLD models, the inhibition of 
Akt has been related to the onset of insulin resistance, whereas the increased expression 
of both SREBP-1c and PPARγ seems to contribute to the accumulation of FFAs through the 
inhibition of beta oxidation [5-8]. Those events could be modulated by the constitutively 
active AMPK [9].
Furthermore, the triggering of hepatic inflammation would be caused by the activation 
of pattern recognition receptors (PRRs), such as toll-like receptors (TLRs) and NLRP3 
inflammasome [10]. Consistent with this hypothesis, the stimulation of TLR4 was reported 
to induce the activation of nuclear factor kappa-light-chain-enhancer of activated B cells 
(Nf-kB), mitogen-activated protein kinase (MAPK) and extracellular signal regulated kinase 
(ERK), which would eventually trigger the production of proinflammatory cytokines and the 
activation of hepatic stellate cells (HSC) [11, 12].
It is to note that estrogens have been proposed to counteract fat deposition in liver with 
beneficial effects against NAFLD [13].
These data might explain, at least in part, the lower incidence of NAFLD in premenopausal 
women in comparison to men [14] and the reported accelerated progression of NAFLD after 
the menopause [15]. For those reasons, estrogen supplementation has been suggested 
as potential treatment for the prevention of NAFLD development and progression in 
postmenopausal women [14, 16].
Interestingly, genistein, the soybean-derived isoflavone, was shown to ameliorate 
high-fat-diet-induced NAFLD in mice, and to counteract its progression towards NASH [17, 
18]. Taking into account the adverse hepatic effects described for the use of estrogens as 
hormone replacement therapy (HRT), phytoestrogens may well represent an alternative for 
the treatment of NAFLD after menopause [15].
Although the involvement of the above reported pathways has been hypothesized, the 
exact mechanisms implied in the protective effects elicited by estrogens and phytoestrogens 
remain mostly poor understood.
For this reason, in this study we examined the effects of 17β-estradiol and genistein 
against fatty changes in Huh7.5 cells and the related involvement of TLR4, NLRP3 
inflammasome, Nf-kB, AMPK, and Akt. The role of estrogenic receptors (ERs) and G protein-
coupled estrogen receptor (GPER) was analyzed, as well.
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Materials and Methods
Culture of Huh7.5 cells
Huh7.5 cells (male immortalized human hepatoma cell line) were obtained from the American Type 
Culture Collection (ATCC; Rockville, Maryland, USA), and were maintained in Dulbecco’s modified Eagle’s 
medium-F-12 (DMEM/HAM’S F-12; Euroclone, Pero, Milan, Italy) supplemented with 10% fetal bovine 
serum (FBS; Euroclone), 2 mM L-glutamine (Euroclone), 1% penicillin-streptomycin (P/S; Euroclone), at 
37°C with 5% CO2 in incubator.
Isolation of hepatocytes from human liver biopsy specimens
The specimens were acquired from the non-neoplastic portion of the resected liver parenchyma at 
the of the surgery. The Ethics Committee of the University Hospital Maggiore of Charity of Novara approved 
the use of bioptic samples, remaining after the routine histologic analysis which is executed for the clinical 
management of patients, for experimental purposes. As required by Ethics Committee of the University 
Hospital Maggiore of Charity of Novara, all tissue donors gave informed consent for experimental use of 
clinical data and liver specimen prior to surgery, and bioptic samples were handled in anonymous conditions. 
Then fresh samples were immediately transferred in ice cold physiologic saline solution to Physiology 
laboratory, and hepatocytes were isolated immediately, as previously performed [19]. The cell suspension 
was filtered through a nylon mesh, washed three times in Hanks buffer and then, cells were resuspended in 
complete growth medium DMEM/HAM’S F-12 (Euroclone) supplemented with 10% FBS (Euroclone) and 
transferred into 75-cm2 culture flasks (Euroclone) in incubator under standard conditions. The culturing 
was performed until passage 15 [19].
Experimental protocol
To reproduce a condition of human NAFLD in vitro, Huh7.5 cells and primary human hepatocytes 
were treated with palmitic acid (Sigma-Aldrich, Milan, Italy) and oleic acid (Sigma), as previously reported 
[20]. In preliminary experiments, cells were incubated in serum-free DMEM/HAM’S F-12 (Euroclone) and 
exposed for 3 h, 24 h and 48 h to increasing concentrations of a fresh mixture of FFAs (0.75 mM, 1.5 mM 
and 2 mM) in a molar ratio of 2:1 oleic:palmitic acid. This mixture was supplemented with 0.25% bovine 
serum albumin (BSA; Sigma) in order to increase stability and solubility of FFAs [20-22]. At the end of 
preliminary experiments performed on cell viability, the concentration of 2 mM of FFAs administered for 3 
h of stimulation, was chosen for all subsequent experiments.
Cell viability
Cell viability was examined in Huh7.5 cells and primary human hepatocytes by using the 1% 
3-[4, 5-dimethylthiazol-2-yl]-2, 5-diphenyl tetrazolium bromide (MTT; Life Technologies Italia, Monza, 
Italy) dye, as previously described  [23-26]. For the experiments, 10000 cells/well were plated in 96-well 
plates.
Huh7.5 cells were stimulated with different concentrations of genistein (10 pM, 10 nM, 100 nM, 
1 μM and 10 μM; Sigma) and 17β-estradiol (10 pM, 10 nM and 100 nM, for 30 min) for 30 min. Huh7.5 cells 
were also stimulated with specific inhibitors administrated for 30 min before the treatment with genistein 
and 17β-estradiol: the PI3K inhibitor, wortmannin (1 nM; Sigma), the NLRP3 inflammasome inhibitor, 
MCC950 (1 nM; Aurogene, Rome, Italy), the AMPK inhibitor, dorsomorphin (1 nM; Sigma), the ERs inhibitor, 
fulvestrant (1 nM; Sigma), the GPER inhibitor, G15 (1 nM; Sigma) and the TLR4 inhibitor, TLR4-IN-C34 
(1 nM; Sigma). After the exposure to these agents, the medium was changed and new fresh medium with 
2 mM FFAs was added for 3 h [27]. Furthermore, a second pool of cells was also stimulated with tumor 
necrosis factor α (TNFα) 200 pM administrated for 3 h in co-stimulation with 2 mM FFAs, either alone or 
before genistein (10 pM and 100 nM) and 17β-estradiol (10 pM and 100 nM). The experimental protocol is 
shown in Flowchart (Fig. 1).
The same experimental protocol was followed for primary human hepatocytes, that were, however, 
stimulated with two concentrations of genistein (10 pM and 1 μM for 30 min) and 17β-estradiol (10 pM and 
100 nM for 30 min) only, without inhibitors.
At the end of each treatment, the medium was removed, and fresh culture medium without red 
phenol and FBS and with MTT dye was added in 96-well plates containing the cells and incubated for 2 h at 
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37°C in an incubator. Thereafter, the medium was removed, and an MTT solubilization solution (dimethyl 
sulfoxide; DMSO; Sigma) in equal volume to the original culture medium was added and mixed in a gyratory 
shaker until the complete dissolution of formazan crystals. Cell viability was determined by measuring the 
absorbance through a spectrometer (VICTOR™ X Multilabel Plate Reader; PerkinElmer) at a wavelength of 
570 nm and cell viability was calculated by setting control cells as 100%. Experiments were conducted in 
triplicate and repeated at least five times.
Mitochondrial membrane potential measurement
Mitochondrial membrane potential measurement in Huh7.5 cells and human primary hepatocytes 
was performed with JC-1 assay following the same experimental protocol described for MTT assay. After 
stimulations, the medium of cells plated in starvation medium was removed and incubated with 5, 51, 
6,61-tetrachloro-1, 11, 3,31 tetraethylbenzimidazolyl carbocyanine iodide (JC-1; Cayman Chemical; Ann 
Arbor, Michigan, USA) 1X diluted in Assay Buffer 1X for 15 min at 37°C in an incubator, following the 
manufacturer’s instruction (Cayman Chemical, Ann Arbor, MI, USA; catalogue number 10009172) and as 
previously performed [23-26]. After incubation, the cells were washed twice with Assay Buffer 1X and then 
the mitochondrial membrane potential was determined by measuring the red (excitation 550 nm/emission 
600 nm) and green (excitation 485 nm/emission 535 nm) fluorescence through a spectrometer (VICTOR™ 
X Multilabel Plate Reader; PerkinElmer). To identify cells undergoing apoptosis, the ratio of fluorescent 
intensity of J-aggregates to fluorescent intensity of monomers was used as an indicator of cell health. The 
data were normalized versus control cells. Experiments were conducted in triplicate and repeated at least 
five times.
ROS quantification
The oxidation of 2,7-dichlorodihydrofluorescein diacetate (H2DCFDA) into 2,7-dichlorodihydrofluo-
rescein (DCF) was used to assess ROS generation, following the manufacturer’s instructions (Abcam, Cam-
bridge, United Kingdom). For ROS production, 25000 Huh7.5 cells or primary human hepatocytes per well 
were plated in 96-well plates, and the same experimental protocol used for MTT and JC-1 assays was fol-
lowed, although using only two concentrations of genistein (10 pM and 1 μM, for 30 min) and 17β-estradiol 
(10 pM and 100 nM, for 30 min), without TNFα.
After treatments, the reactions were stopped by removing the medium and washing with phosphate 
buffer saline (PBS) followed by staining with 10 µM H2DCFDA for 20 min at 37°C. The fluorescence 
intensity of DCF was measured at an excitation and emission wavelength of 485 nm and 530 nm by using a 
Fig. 1. Flowchart of experimental protocol. Huh7.5 cells and human primary hepatocytes were treated 
with 2 mM free fatty acids (FFAs) for 3 h, in presence or absence of 200 pM TNFα administrated for 3 h in 
co-stimulation with 2 mM FFAs. In some experiments, genistein and 17β-estradiol were given for 30 min 
before FFAs administration, in presence or absence of wortmannin, MCC950, dorsomorphin, fulvestrant, 
G15 and TLR4-IN-C34, which were administrated for 30 min before genistein and 17β-estradiol. After the 
exposure to the above agents, specific assays were performed. MTT: 1% 3-[4,5-dimethylthiazol-2-yl]-2,5-
diphenyl tetrazolium bromide; JC: 5,51,6,61-tetrachloro-1,11,3,31 tetraethylbenzimidazolyl carbocyanine 
iodide; DCFDA: 2,7-dichlorodihydrofluorescein diacetate; wortmannin: PI3K inhibitor; MCC950: NLRP3 
inflammasome inhibitor; dorsomorphin: AMPK inhibitor; fulvestrant: estrogenic receptors inhibitor; G15: 
G protein-coupled estrogen receptor inhibitor; TLR4-IN-C34: toll like receptor 4 inhibitor.
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spectrophotometer (VICTOR™ X Multilabel Plate Reader; PerkinElmer) [24-26]. The amount of intracellular 
ROS was proportional to the intensity of DCF fluorescence, and the fluorescence intensity was recorded 
directly to indicate the relative amount of ROS. Results were expressed as DCF fluorescence intensity, which 
is proportional to the amount of intracellular ROS. Experiments were conducted in triplicate and repeated 
at least five times.
Triglycerides content
For intracellular quantification of triglycerides in Huh7.5 cells, the Triglyceride Colorimetric Assay was 
used according to the manufacturer’s instructions (Cayman Chemical), using 1800000 cells/well. The same 
experimental protocol described for ROS production was adopted. Briefly, after treatments, cells were lysed 
in cold Standard Diluent, by using a rubber policeman (not using proteolytic enzymes) and then sonicated. 
The cell pellet was centrifuged at 10 000 g for 10 min at 4°C and the supernatant was collected and diluted 
1:2 before the assay.
Ten µl of each dilute sample was transferred to a 96-well plate and 150 µl of Enzyme Mixture solution 
was added to each well in order to start the reaction. The plate was covered and incubated for 15 min at 
room temperature. The absorbance at 530 nm-550 nm, was red by using a spectrophotometer (VICTOR™ 
X Multilabel Plate Reader; PerkinElmer). The value of each sample was quantified in respect to triglyceride 
standard curve and expressed as triglyceride content (mg/dl). Experiments were conducted in triplicate 
and repeated at least five times.
Cell lysates
For protein expression/activation examination, Huh7.5 cells were stimulated with genistein 10 pM 
and 17β-estradiol 10 pM for 30 min before the treatment with 2 mM FFAs for 3 h. At the end of stimulation, 
Huh7.5 cells were lysed in iced Ripa buffer supplemented with sodium orthovanadate (2 mM; Sigma) and 
protease inhibitors cocktail (1 mM; Thermo Fisher Scientific) and phenylmethanesulfonyl fluoride (1 mM; 
Sigma). The extracted proteins were quantified through bicinchoninic acid protein (BCA, Pierce) and used 
for electrophoresis and immunoblotting studies. Experiments were conducted in triplicate and repeated at 
least five times
Western blot analysis
Cell lysates (30 μg protein each sample) were dissolved in 5X Laemmli buffer, boiled for 5 min and 
resolved in 10% sodium dodecyl sulfate polyacrylamide gel electrophoresis gels (Bio-Rad Laboratories). 
After electrophoresis they were transferred to polyvinylidene fluoride membranes (Bio-Rad Laboratories), 
which were incubated overnight at 4°C with specific primary antibodies: anti Nf-kB p50 (1:1000; Santa 
Cruz Biotechnology), anti PPAR-γ (1:1000; Santa Cruz Biotechnology; catalogue number sc-271392), 
anti p-AMPKα1/2 (1:1000; Thr 172; Santa Cruz Biotechnology), anti AMPKα1/2 (1:1000; Santa Cruz 
Biotechnology), anti phospho-Akt (1:1000; Ser 473, Santa Cruz Biotechnology), anti Akt (1:1000; Santa Cruz 
Biotechnology).
The membranes were washed and then incubated with horseradish peroxidase-coupled goat anti-
rabbit IgG (Sigma), peroxidase-coupled rabbit anti-goat IgG and horseradish peroxidase-coupled goat 
anti-mouse IgG (Sigma) for 45 min and were developed through a non-radioactive method using Western 
Lightning Chemiluminescence (PerkinElmer Life and Analytical Sciences). Phosphorylated protein 
expression was calculated as a ratio towards specific total protein expression or β-actin (1:5000; Santa Cruz 
Biotechnology) detection.
Statistical analysis
All data were recorded using the Institution’s database. Statistical analysis was performed by using 
STATVIEW version 5.0.1 for Microsoft Windows (SAS Institute Inc., Cary NC, USA). Data were checked for 
normality before statistical analysis. All the results obtained were examined through one-way ANOVA 
followed by Bonferroni post hoc tests. All data are presented as means ± standard deviation (SD) of five 
independent experiments for each experimental protocol. A value of P <0.05 was considered statistically 
significant.
Cell Physiol Biochem 2020;54:401-416
DOI: 10.33594/000000227
Published online: 25 April 2020 406
Cellular Physiology 
and Biochemistry
© 2020 The Author(s). Published by 
Cell Physiol Biochem Press GmbH&Co. KG
Farruggio et al.: Protective Effects Exerted by Estrogens/Phytoestrogens Against NAFLD
Results
In the first part of the study, we 
aimed to examine the protective effects 
elicited by genistein and 17β-estradiol 
on cell viability, mitochondrial function, 
triglycerides accumulation and oxidative 
stress of hepatocytes cultured in oleate/
palmitate medium. A dose-response 
effect analysis was performed in order 
to choose the optimal dosage of both 
estrogens/phytoestrogens to be adopted 
in the second part of the study.
As shown in Fig. 2, genistein and 
17β-estradiol were able to increase cell 
viability and mitochondrial membrane 
potential in Huh7.5 cells treated with 
FFAs. Moreover, both agents were able 
to counteract the increased ROS release 
and triglycerides overaccumulation 
caused by FFAs in Huh7.5 cells (Fig. 
3). The protective effects elicited by 
genistein and 17β-estradiol in Huh7.5 
cells were also confirmed by experiments 
performed in presence of TNFα. Hence, 
both estrogens and phytoestrogens 
reduced the deleterious effects elicited by 
TNFα on cell viability and mitochondrial 
membrane potential (Fig. 4). Also, 
in primary human hepatocytes, both 
genistein and 17β-estradiol were able to 
prevent the damages caused by FFAs (Fig. 
5).
Note that no differences in the effects 
of genistein from 10 pM up to 1 μM were 
observed on Huh7.5 cells. On cell viability 
and mitochondrial membrane potential 
the lowest response was found at 10 μM 
genistein. For this reason, all subsequent 
experiments were performed with 1 
μM genistein. Similarly, as regarding 
estradiol, no grading was observed with 
10 pM-100 nM. Thus, 10 nM estradiol was 
used to execute all other experiments.
In the second part of the study, the 
involvement of PI3K/Akt, AMPK, TLR4, NLRP3 inflammasome, ERs and GPER was examined 
by performing the same experiments of the first part in presence of specific inhibitors. In 
addition, Western Blot was executed in order to better address the role of Akt, AMPK, Nf-kB 
and PPARγ.
Fig. 2. Effects of genistein and 17β-estradiol on cell 
viability (A) and mitochondrial membrane potential 
(B) in Huh7.5 cells. In A and B, the effects of genistein 
(G) and 17β-estradiol (E), are shown. Data were 
normalized versus related control values. C=control 
(non-treated cells); FFAs=free fatty acids (2 mM for 3 
h). Reported data are means ± SD of five independent 
experiments for each protocol. Significance between 
groups: *P<0.05 vs. C; # P <0.05 vs FFAs. Short 
square brackets indicate significance between groups 
(P<0.05).
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Fig. 3. Effects of genistein and 17β-estradiol on 
ROS production (A) and triglycerides content 
(B) in Huh7.5 cells. In A, results are expressed as 
DCF fluorescence intensity, which is proportional 
to the amount of intracellular ROS. In B, results 
are expressed as triglycerides content (mg/dl) 
produced after each stimulation. G: genistein; 
E: 17β-estradiol. C=control (non-treated cells); 
FFAs=free fatty acids. Reported data are means 
± SD of five independent experiments for each 
experimental protocol. Significance between 
groups: *P<0.05 vs C; #p<0.05 vs. FFAs.
Fig. 4. Effects of genistein and 17β-estradiol on cell 
viability (A) and mitochondrial membrane potential 
(B) in Huh7.5 cells in presence of tumor necrosis 
factor (TNFα). Data were normalized against 
the control value. G: genistein; E: 17β-estradiol. 
C=control (non-treated cells); FFAs=free fatty acids. 
Reported data are means ± SD of five independent 
experiments for each experimental protocol. 
Significance between groups: * P <0.05 vs. C; # P 
<0.05 vs FFAs; χ P <0.05 vs. TNFα.
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In presence of wortmannin, dorsomorphin, G15 and fulvestrant, the effects of genistein 
and 17β-estradiol on cell viability, mitochondrial membrane potential, ROS release and 
triglycerides accumulation caused by FFAs in Huh7.5 cells were generally counteracted (Fig. 
6 and 7).
As regarding TLR4, the administration of TLR4-IN-C34 reduced the damages caused 
by FFAs but was not able to affect the response of Huh7.5 cells to neither genistein nor 
17β-estradiol (Fig. 6 and 7). Conversely, the NLRP3 inflammasome inhibitor, MCC950, was 
able to potentiate the protective effects elicited on Huh7.5 cells by both agents (Fig. 6 and 7).
The involvement of Akt and AMPK in the protective effects elicited by both estrogens 
and phytoestrogens in Huh7.5 cells treated with FFAs was confirmed by Western blot, as 
well (Fig. 8A and B). In addition, also NF-kB and PPARγ were found to play a role. As shown 
in Fig. 8C and D, both genistein and 17β-estradiol not only increased the activation of Akt and 
AMPK but were also able to reduce the expression of Nf-kB and PPARγ.
Fig. 5. Effects of genistein 
and 17β-estradiol on cell 
viability (A), mitochondrial 
membrane potential (B) 
and ROS production (C) on 
primary human hepatocytes. 
G: genistein; E: 17β-estradiol. 
C=control (non-treated 
cells); FFAs=free fatty 
acids. Reported data are 
means ± SD of at least five 
independent experiments for 
each experimental protocol. 
Significance between groups: 
* P <0.05 vs. C; # P <0.05 vs. 
FFAs. Short square brackets 
indicate significance among 
groups (P <0.05).
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Discussion
The results of this study show that both genistein and 17β-estradiol protect both 
Huh7.5 cells and human primary hepatocytes against intracellular fat overaccumulation 
by preserving mitochondrial function through the modulation of the oxidants/antioxidants 
balance. These effects are seen to involve pathways underlying the mechanisms of 
triglycerides accumulation and hepatic inflammation.
In our study, we employed an established human hepatoma cell model of NAFLD and 
related progression to NASH made of Huh7.5 cells exposed to a mixture of oleate/palmitate 
[19-22, 28], which are common long chains fatty acids in the Western diet and the most 
abundant fatty acids in normal and steatotic liver [20]. As previously shown, treatment 
with a 2:1 ratio oleic/palmitic acids mixture induced steatosis in both Huh7.5 cells and 
primary human hepatocytes [29]. It is to note that we used a fatty acids concentration 
similar to the plasmatic levels found in patients with metabolic syndrome [20]. Moreover, 
we observed that the fat overaccumulation in Huh7.5 cells was accompanied by a diminution 
of the mitochondrial membrane potential associated with an increased in ROS release, 
which ended in reduced cell viability. Similar deleterious effects were observed in primary 
human hepatocytes. Both genistein and 17β-estradiol were able to prevent the ectopic 
accumulation of fat in Huh7.5 cells and primary human hepatocytes where, consequently, a 
Fig. 6. Effects of genistein and 
17β-estradiol on cell viability (A) 
and mitochondrial membrane 
potential (B) in Huh7.5 cells in 
presence/absence of inhibitors. 
G: genistein; E: 17β-estradiol. 
C=control (untreated cells); 
FFAs=free fatty acids. WORT (1 
nM wortmannin for 30 min); 
MCC950 (NLRP3 inhibitor; 1 
nM for 30 min); DORSOM (1 
nM dorsomorphin for 30 min); 
G15 (1 nM for 30 min); FULV 
(fulvestrant; 1 nM for 30 min); 
TLR4-IN-C34 (TLR4 inhibitor; 
1 nM for 30 min). Reported 
data are means ± SD of five 
independent experiments for 
each experimental protocol. 
Significance between groups: 
* P <0.05 vs C; # P <0.05 vs 
FFAs; φ P <0.05 vs G 10 pM; δ P 
<0.05 vs. E 10 pM. Short square 
brackets indicate significance 
among groups (P <0.05).
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reduction in the release of ROS and the recovery of the mitochondrial membrane potential 
were also observed. Note that the doses of genistein used for the study were in the range of 
nutritional concentrations and comparable to those administrated in previous works using 
cellular models [30, 31]. 17β-estradiol was also used at concentrations referable to those of 
menstrual or menopausal women and comparable to those given to Huh7.5 cells in previous 
studies [32-34]. Both genistein and 17β-estradiol were also able to limit the deleterious 
effects of TNFα, which was used to induce inflammatory stress in Huh7.5 cells.
NAFLD is characterized by a diffused fat accumulation in vesicles that displace the 
cytoplasm of hepatocytes, i.e., steatosis. So far, the underlying mechanism behind the 
development of NAFLD and its progression towards fibrosis and NASH has not been fully 
elucidated. Historically, ‘‘two-hit’’ hypothesis was used to explain the pathogenesis of NAFLD. 
However, this view was considered to be too simplistic to summarize the synergy of multiple 
stimulating factors in the occurrence of NAFLD. Presently, NAFLD is rather inclined to be a 
‘‘multiple hit’’ disease [35]. Such hits involve genetic, metabolic and environmental factors 
including epigenetic modifications, dietary intake, hormones (leptin, adiponectin) secreted 
from adipose tissue, crosstalk between different organs or tissues and so on. Among these 
factors, at cellular level oxidative stress and mitochondria play a primary role as starting 
point [2, 36].
Fig. 7. Effects of genistein 
and 17β-estradiol on ROS 
production (A) and triglycerides 
content (B) in Huh7.5 cells in 
presence/absence of inhibitors. 
G: genistein; E: 17β-estradiol. 
C=control (untreated cells); 
FFAs=free fatty acids. Reported 
data are means ± SD of five 
independent experiments for 
each experimental protocol. 
Significance between groups: 
* P <0.05 vs C; # P <0.05 vs 
FFAs; φ P <0.05 vs G 10 pM; δ P 
<0.05 vs. E 10 pM. Short square 
brackets indicate significance 
among groups (P <0.05).
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In this regard, it’s well known that fat and energy homeostasis in hepatocytes are 
regulated by mitochondrial activities, including β-oxidation and production of ATP [4]. 
Mitochondrial dysfunction modifies the balance between oxidants/antioxidants, leading 
to an increase of non-metabolized FFAs in the cytosol and the consequent induction of 
ROS release. In turn, an increased overload of FFAs into mitochondria would augment the 
permeability of the inner mitochondrial membrane leading to dissipation of the membrane 
potential. Moreover, the increase of fatty acid oxidation could generate an “electron leakage” 
ensuring a direct reaction between electrons and oxygen. All above events would result in an 
increased release of ROS [3]. Given these roles of mitochondria in energy homeostasis and 
ROS production, it is reasonable to suppose that any mitochondrial defect in hepatocyte can 
flow to NAFLD [21].
Our results showing that both genistein and 17β-estradiol act by preserving the 
mitochondrial membrane potential in both Huh7.5 cells and primary human hepatocytes is 
a novel finding with potential clinical relevance.
Besides to oxidative stress, inflammation also plays a relevant role in the pathophysiology 
of NAFLD and its progression toward NASH and cancer. Hepatic inflammation is considered 
not only the main driver of hepatic tissue damage, but also the factor that triggers the 
progression from NAFLD to severe fibrogenesis and, ultimately, hepatocellular carcinoma 
[10].
In this context, the activation of proinflammatory pathways via hepatic receptors such 
as TLRs and NOD-like receptors has longstanding recognition [37, 38]. Among various TLRs 
and NOD-like receptors, TLR4 and inflammasome NLRP3 are widely considered to have 
Fig. 8. Changes in Akt and 
AMPKα1/2 phosphorylation (A 
and C) and Nf-kB and PPARγ 
expression (B and D) in Huh7.5 
cells. Densitometric analysis and 
an example of Western blot taken 
from 5 different experiments are 
shown. AMPKα1/2: AMP-activated 
protein kinase α1/2; Nf-kB: nuclear 
factor kappa-light-chain-enhancer 
of activated B cells; PPARγ: 
peroxisome proliferator activating 
ligand receptors γ; G: genistein; 
E: 17β-estradiol. C=control 
(untreated cells); FFAs=free fatty 
acids (2 mM for 3 h). The data were 
normalized versus control value. 
Reported data are means ± SD of 
three independent experiments 
for each experimental protocol. 
Significance among groups: 
* P <0.05 vs. C; # P <0.05 vs FFAs.
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relevance in liver inflammation and fibrogenesis [39, 40]. Downstream TLR4, there would be 
the activation of NF-kB, MAPK [41] and extracellular signal regulated kinase-1 (ERK1), which 
finally would trigger the production of proinflammatory cytokines [10, 42]. This activation, 
in turn, would up-regulate the transcription of NLRP3 inflammasome-related components, 
which would potentiate cytokines release and liver damage
Our observation that FFAs treatment of Huh7.5 cells leads to an increase of the expression 
of the Nf-kB, is an important acquisition. TLR4 and inflammasome NLRP3 are also found to 
be involved in mediating the damages caused by fatty acids as shown by the experiments 
in presence or absence of specific inhibitors. Hence, while the administration of MCC950 
was able to improve cell viability and mitochondrial potential and reduce ROS release and 
triglycerides accumulation, TLR4-IN-C34 caused the opposite effect. Furthermore, in Huh7.5 
cells treated with MCC950 a potentiation of the protective effects elicited by genistein 
and 17β-estradiol was observed. This suggests, for the first time, involvement of NLRP3 
inflammasome pathway in the mechanism with which estrogens and phytoestrogens act to 
reduce the ectopic accumulation of fat within hepatocytes.
Both FFAs synthesis and catabolism are regulated by factors like SREBP-1c, the 
carbohydrate response element binding protein (ChREBP) and PPARs, among which PPAR-γ, 
whose expression in conditions of liver damage is usually high, that would particularly 
contribute to the accumulation of FFAs [43-45]. Since, the use of PPAR-γ agonists has been 
shown to reduce lipotoxicity in the liver [46], PPAR-γ is considered as a drug target for type 
2 diabetes and other components of metabolic syndrome.
NAFLD pathogenesis also involves AMPK that acts as a sensor of the energy levels, 
stimulating mitochondrial β-oxidation and lipogenesis [47]. Following phosphorylation at 
Thr 172, AMPK would inhibit rate-limiting steps in lipogenesis, such as SREBP-1C, through 
mammalian target of rapamycin in hepatic cells. Conversely, AMPK inhibition has been 
shown to counteract those effects, accelerating fatty liver development [9].
As concerning the mechanisms through which genistein and 17β-estradiol could hinder 
the harmful effects of FFAs in Huh7.5 cells, the results of the present study suggest a role for 
both PPAR-γ and AMPK. Hence, both agents were able to reduce the increased expression 
of PPAR-γ and the reduced phosphorylation of AMPK at Thr 172, caused by fatty acids. In 
this context, the actions of genistein and 17β-estradiol on AMPK resemble those elicited by 
the anti-diabetic drug metformin [48]. It is to note that also metformin was able to preserve 
mitochondrial membrane potential in HepG2 cells and primary rat hepatocytes treated with 
palmitate [49].
Overall, our observations are consistent with in vitro studies performed with HepG2 
cells showing an increase of the expression of PPARs in response to 10 μM genistein [50]. 
Also, in BRL cells treated with a mixture of fatty acids, genistein was capable to counteract 
fat overaccumulation through regulation of fatty acids metabolism mediated by AMPK [51].
As regarding 17β-estradiol, the experimental results acquired with the present study 
are in line with the known beneficial effects exerted by estrogens in liver metabolic dys-
homeostasis [52]. Estrogens act suppressing lipid accumulation, inflammation, and fibrosis 
slowing down NAFLD/NASH progression in premenopausal.
Liver has both nuclear ERs and GPER, too. Previous findings have reported that the 
activation of ERK1/2, Akt, MAPK could act as downstream signaling of both ERs and GPER 
stimulation [53-56]. As also shown in Huh7.5 cells and HSC [33], fulvestrant and G15 were 
able to reduce the damages caused the ectopic accumulation of fat in hepatocytes and to 
prevent the beneficial effects exerted by both estrogens and phytoestrogens.
Although not clearly examined, it could be speculated that genistein and 17β-estradiol 
counteract the effects of FFAs in hepatocytes by the activation of signalling pathways, 
downstream ERs and GPER, involving AMPK and PPAR-γ. This would be followed by the 
reduction of the oxidative stress and inflammation and preservation of the mitochondrial 
membrane potential. Finally, both phytoestrogens and estrogens may protect hepatocytes 
against NAFLD by activating kinases engaged in the modulation of the insulin pathway such 
as Akt.
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Conclusion
Taken together, our findings would highlight novel mechanisms of action through which 
both genistein and 17β-estradiol could exert protective effects against NAFLD with potential 
clinical implications. While the prevalence of NAFLD is increasing worldwide, no therapies 
have been approved for this condition. In addition, the higher prevalence of NAFLD/NASH 
in men and postmenopausal women compared to premenopausal women, and experimental 
data showing the protective effects of estrogen in the liver, would indicate that estrogens 
are involved in NAFLD. Very few studies have shown a beneficial effect of HRT on NAFLD, 
although adverse hepatic effects have been attributed to progesterone. In this context, 
phytoestrogens could represent alternatives to HRT, although their long-term efficacy and 
safety remain to be shown [15]. Further studies are needed to better address those issues 
and improve the current knowledge of the mechanisms of action involving various pathways 
and related cross talks.
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